FDA Considers Making Narcan Opioid Overdose Antidote Available Without Prescription

Two hands cradling a nasal spray dispenser for naloxone.
February 15, 2023
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Summer Programs of Innovation and Diversity

LEADER/PEPP Program participants and leaders sitting together at an outdoor table for lunch.
September 6, 2022
This summer, the office of Diversity, Equity, Accessibility, and Inclusion (DEAI), hosted two intensive summer research programs: Project Engage Pharmacy Program (PEPP) Camp and the Leadership Through Engagement For the Advancement of Diverse Educational Research (LEADER) Program.

Reveles and Evoy Earn Promotions

A woman and a man smiling.
February 25, 2022
Two of the college's distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell. Dr. Kelly R. Reveles will assume the rank of associate professor and Dr. Kirk Evoy will become a clinical associate professor. Both promotions go into effect September 1, 2022.

Peppas to Receive Prestigious Oesper Award in Honor of Contributions to Chemistry

A smiling man standing in front of a bookshelf.
November 4, 2020
Nicholas A. Peppas, Sc.D. has been honored with the 2020 Oesper Award from the University of Cincinnati’s Chemistry Department and the Cincinnati Section of the American Chemical Society for his outstanding accomplishments in and contributions to science. The award recognizes his work in biomaterials, drug delivery, bionanotechnology, and nanomaterials.

In Remembrance of Dr. Ted Mills

A man wearing a suit and tie.
October 23, 2020
It is with great sadness that we announce the passing of Edward (Ted) Mills, Ph.D., associate professor in the Division of Pharmacology and Toxicology and Bergen Brunswig Corporation Centennial Fellow.

Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Richburg Receives NIH Grant Award for Toxicant Injury Research

A man smiling
August 10, 2020
Associate Dean for Research and Graduate Studies John H. Richburg, Ph.D. received notice from the National Institutes of Health (NIH) awarding him a research grant for a five-year term. The NIH’s grant award for Dr. Richburg’s research totals $2,694,316.